The World Health Organization is temporarily suspending the use of hydroxychloroquine from its global study into experimental treatments for the coronavirus.
WHO Director-General Tedros Adhanom Ghebreyesus said in a news briefing Monday that a study published last week showed those taking hydroxychloroquine had a greater risk of heart problems and death.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
